OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2763-2774
Open Access | Times Cited: 31
Arian Lundberg, Meng Zhang, Rahul Aggarwal, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2763-2774
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
Lourdes Brea, Jindan Yu
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 4
Lourdes Brea, Jindan Yu
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 4
LKB1 inactivation promotes epigenetic remodeling-induced lineage plasticity and antiandrogen resistance in prostate cancer
Fei Li, Pengfei Dai, Huili Shi, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 59-71
Open Access | Times Cited: 2
Fei Li, Pengfei Dai, Huili Shi, et al.
Cell Research (2025) Vol. 35, Iss. 1, pp. 59-71
Open Access | Times Cited: 2
Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation
Won Kyung Kim, Alyssa J. Buckley, Donghoon Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Won Kyung Kim, Alyssa J. Buckley, Donghoon Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
Sheng‐Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 13
Sheng‐Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 13
ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer
Chen Qian, Qian Yang, Mirja Rotinen, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7740-7760
Open Access | Times Cited: 8
Chen Qian, Qian Yang, Mirja Rotinen, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 13, pp. 7740-7760
Open Access | Times Cited: 8
An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression
Raunak Shrestha, Lisa N. Chesner, Meng Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3086-3100
Closed Access | Times Cited: 8
Raunak Shrestha, Lisa N. Chesner, Meng Zhang, et al.
Cancer Research (2024) Vol. 84, Iss. 18, pp. 3086-3100
Closed Access | Times Cited: 8
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function
Anbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 14
Anbarasu Kumaraswamy, Zhi Duan, Diana Flores, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 14
Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression
Meng Zhang, Martin Sjöström, Xiekui Cui, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 7, pp. 1176-1186
Closed Access | Times Cited: 4
Meng Zhang, Martin Sjöström, Xiekui Cui, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 7, pp. 1176-1186
Closed Access | Times Cited: 4
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
Pradeep S. Chauhan, Irfan Alahi, Savar Sinha, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 1, pp. 151-163
Closed Access | Times Cited: 4
Pradeep S. Chauhan, Irfan Alahi, Savar Sinha, et al.
Clinical Cancer Research (2024) Vol. 31, Iss. 1, pp. 151-163
Closed Access | Times Cited: 4
LKB1 inactivation unleashes prostate cancer lineage plasticity
Shaghayegh Nouruzi, Amina Zoubeidi
Cell Research (2025)
Closed Access
Shaghayegh Nouruzi, Amina Zoubeidi
Cell Research (2025)
Closed Access
IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer
Yetunde Oyende, Luke J. Taus, Alessandro Fatatis
Cancers (2025) Vol. 17, Iss. 2, pp. 290-290
Open Access
Yetunde Oyende, Luke J. Taus, Alessandro Fatatis
Cancers (2025) Vol. 17, Iss. 2, pp. 290-290
Open Access
CPSF1 inhibition promotes widespread use of intergenic polyadenylation sites and impairs glycolysis in prostate cancer cells
Kiel T. Tietz, Braedan M. McCluskey, Conor R. Miller, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115211-115211
Open Access
Kiel T. Tietz, Braedan M. McCluskey, Conor R. Miller, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115211-115211
Open Access
Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer
Samuel P. Pitzen, Amber N. Rudenick, Yinjie Qiu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Samuel P. Pitzen, Amber N. Rudenick, Yinjie Qiu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 6
Open Access
Aggressive Varianten und transdifferenziertes neuroendokrines Prostatakarzinom: Von der Diagnose zur Therapie
Gunhild von Amsberg, Sergey A. Dyshlovoy, Moritz Kaune
Deleted Journal (2025)
Closed Access
Gunhild von Amsberg, Sergey A. Dyshlovoy, Moritz Kaune
Deleted Journal (2025)
Closed Access
Adverse prognosis gene expression patterns in metastatic castration‐resistant prostate cancer
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, et al.
Molecular Oncology (2025)
Open Access
Marina N. Sharifi, Eric Feng, Nicholas R. Rydzewski, et al.
Molecular Oncology (2025)
Open Access
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access
Whole genome sequencing of 378 prostate cancer metastases reveals tissue selectivity for mismatch deficiency with potential therapeutic implications
Daniël J. Vis, Sander Palit, Marie Corradi, et al.
Genome Medicine (2025) Vol. 17, Iss. 1
Open Access
Daniël J. Vis, Sander Palit, Marie Corradi, et al.
Genome Medicine (2025) Vol. 17, Iss. 1
Open Access
Transcriptional profiles of circulating tumor cells reflect heterogeneity and treatment resistance in advanced prostate cancer
Lina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Lina Bergmann, Sarah Greimeier, Sabine Riethdorf, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
The Influence of the Germline HSD3B1 Adrenal-Permissive Allele (C.1100 C) on the Somatic Alteration Landscape, the Transcriptome, and Immune Cell Infiltration in Prostate Cancer
Samuel Kellen, Allison Makovec, Carly D. Miller, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1270-1270
Open Access
Samuel Kellen, Allison Makovec, Carly D. Miller, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1270-1270
Open Access
Signalling pathways in a nutshell: from pathogenesis to therapeutical implications in prostate cancer
Aviv Philip Goncharov, Constantinos Dicusari Elissaiou, Elad Ben Aharon Farzalla, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Aviv Philip Goncharov, Constantinos Dicusari Elissaiou, Elad Ben Aharon Farzalla, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Glucocorticoid receptor action in prostate cancer: the role of transcription factor crosstalk
Johannes Hiltunen, Laura Helminen, Ville Paakinaho
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Johannes Hiltunen, Laura Helminen, Ville Paakinaho
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment
Carly D. Miller, Pornlada Likasitwatanakul, Eamon Toye, et al.
Expert Review of Anticancer Therapy (2024)
Closed Access | Times Cited: 2
Carly D. Miller, Pornlada Likasitwatanakul, Eamon Toye, et al.
Expert Review of Anticancer Therapy (2024)
Closed Access | Times Cited: 2
The Multifaceted Role of Osteopontin in Prostate Pathologies
Samara V. Silver, Petra Popovics
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2895-2895
Open Access | Times Cited: 5
Samara V. Silver, Petra Popovics
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2895-2895
Open Access | Times Cited: 5
Epigenetic regulation of androgen dependent and independent prostate cancer
Jagdish Mishra, Subhajit Chakraborty, Piyasa Nandi, et al.
Advances in cancer research (2024), pp. 223-320
Closed Access | Times Cited: 1
Jagdish Mishra, Subhajit Chakraborty, Piyasa Nandi, et al.
Advances in cancer research (2024), pp. 223-320
Closed Access | Times Cited: 1
CDHu40: a novel marker gene set of neuroendocrine prostate cancer
Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access | Times Cited: 1
Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 6
Open Access | Times Cited: 1
